CN103981248B - A kind of leucic method of resolution of racemic - Google Patents

A kind of leucic method of resolution of racemic Download PDF

Info

Publication number
CN103981248B
CN103981248B CN201410167153.5A CN201410167153A CN103981248B CN 103981248 B CN103981248 B CN 103981248B CN 201410167153 A CN201410167153 A CN 201410167153A CN 103981248 B CN103981248 B CN 103981248B
Authority
CN
China
Prior art keywords
leucine
leu
methyl ester
dextrorotation
resolution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201410167153.5A
Other languages
Chinese (zh)
Other versions
CN103981248A (en
Inventor
蒋立建
付倩倩
何慧
唐赛杰
顾美萍
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Southeast University
Original Assignee
Southeast University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Southeast University filed Critical Southeast University
Priority to CN201410167153.5A priority Critical patent/CN103981248B/en
Publication of CN103981248A publication Critical patent/CN103981248A/en
Application granted granted Critical
Publication of CN103981248B publication Critical patent/CN103981248B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The present invention is a kind of leucic method of resolution of racemic, the method prepares left-handed leucine and dextrorotation leucine with Enzymatic Resolution racemize leucine and DL-LEUCINE, specifically comprise the following steps: the first step: with racemize leucine for raw material, prepare DL-LEUCINE methyl ester hydrochloride according to thionyl chloride method; Second step: DL-LEUCINE methyl ester hydrochloride is dissolved in alkaline aqueous solution, adds lipase, enzymatic hydrolysis 5 ~ 10 hours at 30 ~ 40 DEG C of temperature, cool to room temperature gradually again, filter out insolubles, obtain left-handed leucine and L-Leu, and retain filtrate; 3rd step: second step gained filtrate continues hydrolysis in the basic conditions, terminates the neutralization of rear diluted acid, filters to obtain dextrorotation leucine and D-Leu.Splitting solvent for use is water, and production cost is low, and environmental pollution is little; Preparation technology is simple, process is purified conveniently, equipment requirements is not high.

Description

A kind of leucic method of resolution of racemic
Technical field
The present invention is a kind of technology of preparing of chiral organic compound, the leucic method of especially a kind of resolution of racemic.
Background technology
L-Leu, in trophology, belongs to the indispensable amino acid of human body.L-Leu can be used as accessory substance, as preparing amino acid transfusion and comprehensive amino acid preparation, with other amino acid actings in conjunction, repairing muscle, controlling blood sugar, to bodily tissue supplying energy.Research shows, leucine can affect the mechanism controlling people's energy i (in vivo) balance [1]; Leucine to human body resistance to fatigue and control muscle and liver starch degraded have remarkable effect [2]; Improve the oxidation capacity of body by the oxidation completing carbohydrate and increase skeletal muscle cell Mitochondria density [3].In addition, leucine also can be used for seasoning sweetener.D-Leu is a kind of alpha-non-natural amino acid, contributes to Perception In Man Before And After Laser stimulation produced analgesia, is expected to the adjuvant as improving Perception In Man Before And After Laser stimulation produced analgesia effect; With D-phenylalanine acting in conjunction, the amino acid composite preparation obtained can be used as the good anodyne for the treatment of horse pain [4], comprise the pain after preoperative, rheumatic arthritis, sprain and pain that overwork etc. causes; Leu derivatives can the aqueous phase aldol reaction of effectively catalyze fatty ketone and aldehyde [5]; With the rare fatty acyl-leucine of N-of leucine preparation synthesis, there is anti-microbial property [6]; Derivative N-acyl group-D-Leu may be used for chiral separation.
About the preparation of D-Leu, the method for bibliographical information mainly contains chemical resolution method, enzyme process and induced crystallization method.
Chemical resolution is correlated with, the combination AES resolving agent formed with the substituted-phenyl ethyl sulfonic acid with optically active 1-Phenyl-ethanesulfonic acid and racemization in patent (a kind of fractionation prepares light amino acid whose method .CN102241555A alive) [7], in aqueous fractionation is carried out to DL-Leu and obtain D-Leu, optical purity 98.2%.And acetonitrile/water ratio be split in the solution of 9:1 time, filter cake in acetonitrile/water solution (9:1) dissolve, drip ammoniacal liquor be 5.98 to pH, obtain D-Leu, optical purity 99.6%.Patent (a kind of method for splitting .CN101659623A of DL-Amino Acid) [8]be resolving agent with D-DBTA, obtain D-Leu, optical purity 98.8%.Document TheResolutionofAminoAcids.II.Isoleucine, Alloisoleucine, LeucineandNorleucine [9]racemize leucine acidylate obtains N-acyl group-DL-LEUCINE; Product and (-)-α-fenchylamine add in hot water, are obtained by reacting double salt; Above-mentioned double salt is purified through fractional crystallization and is obtained N-acyl group-D-Leu (-)-α-fenchylamine double salt in methyl alcohol; the latter's decomposition obtains N-acyl group-D-Leu; then reflux in 3N hydrochloric acid; reaction solution concentrates; after evaporate to dryness; resistates dissolves in methyl alcohol, and adjust pH to iso-electric point with ammoniacal liquor, filtering and obtaining filter cake is D-Leu.Above method, the price comparison of some resolving agents is high, and some intermediates are not easy to carry out aftertreatment, and the then reactions steps had is more, operating process relative complex, inconvenient suitability for industrialized production.
Patent (preparation of N-acyl group-DL-Leu and purposes .CN102617384A) [10]in first by L-Leu racemization in organic acid, obtain DL-Leu, racemize leucine generates N-acyl group-DL-Leu with acylating reagent effects such as diacetyl oxides in inorganic alkali solution; be dissolved in basic solution, added D-L-Aminoacylase, through enzymic hydrolysis; neutralization, is separated, and purifies and obtains D-Leu.This method, reaction conditions is gentle, concise in technology; But D-L-Aminoacylase more not easily obtains, and price comparison is high, in reaction system, L-Leu is not easy to reclaim.
Document OpticalResolutionofDL-AminoAcidsbyPreferentialCrystalliz ationProcedure [11], DL-Leu and Phenylsulfonic acid are made DL-Leu benzene sulfonate.DL-Leu benzene sulfonate is dissolved in water, adds a small amount of D-Leu-BS and do crystal seed, separate out D-Leu benzene sulfonate, separate Phenylsulfonic acid by ion exchange method, obtain D-Leu.Induced crystallization legal system gets D-Leu, extends the production cycle, adds production cost, and the optical purity of product is relatively low, is not suitable for industrial production.Therefore, be necessary to study new method for splitting.
Summary of the invention
Technical problem: the object of this invention is to provide a kind of method that Enzymatic Resolution DL-LEUCINE prepares L-Leu and D-Leu, the method splits that DL-LEUCINE environmental pollution is little, concise in technology, products obtained therefrom optical purity is high and yield is higher.
Technical scheme: the leucic method of resolution of racemic of the present invention prepares left-handed leucine and dextrorotation leucine with Enzymatic Resolution racemize leucine and DL-LEUCINE, specifically comprises the following steps:
The first step: with racemize leucine for raw material, prepares DL-LEUCINE methyl ester hydrochloride according to thionyl chloride method;
Second step: DL-LEUCINE methyl ester hydrochloride is dissolved in alkaline aqueous solution, adds lipase, enzymatic hydrolysis 5 ~ 10 hours at 30 ~ 40 DEG C of temperature, cool to room temperature gradually again, filter out insolubles, obtain left-handed leucine and L-Leu, and retain filtrate;
3rd step: second step gained filtrate continues hydrolysis in the basic conditions, terminates the neutralization of rear diluted acid, filters to obtain dextrorotation leucine and D-Leu.
Described lipase comprises: acid lipase enzyme, neutral lipase, alkaline lipase.
Described diluted acid comprises dilute hydrochloric acid or dilute sulphuric acid, and the concentration of diluted acid is 0.1-2.0mol/L.
Alkaline aqueous solution in described second step alkali used is: NaOH, KOH, NaHCO 3, Na 2cO 3or ammoniacal liquor.
Alkali required for described 3rd step neutral and alkali condition is LiOH, NaOH, KOH, K 2cO 3or Na 2cO 3.
Beneficial effect: the solution of the ester after ferment treatment of the present invention is easier than acid amides in buck to be hydrolyzed; Splitting solvent for use is water, and production cost is low, and environmental pollution is little; Preparation technology is simple, process is purified conveniently, equipment requirements is not high.
Accompanying drawing explanation
Fig. 1 is process route chart of the present invention.
Embodiment
The present invention prepares left-handed leucine and dextrorotation leucine with Enzymatic Resolution DL-Leu, take first DL-Leu as raw material, prepares DL-LEUCINE methyl ester hydrochloride according to thionyl chloride method.Then leucine methyl ester hydrochloride is dissolved in alkaline aqueous solution, add and easily obtain cheap lipase, enzymatic hydrolysis for some time at a certain temperature, then cool to room temperature gradually, filter out insolubles, obtain left-handed leucine (L-Leu).Mother liquor continues hydrolysis in the basic conditions, terminates rear acid neutralization, filters to obtain dextrorotation leucine (D-Leu).This uses lipase selective hydrolysis leucine ester to prepare light leucic method alive first, and compared with preparing D-Leu with use D-L-Aminoacylase, lipase source is more extensive, cheaper, and L-Leu is convenient to reclaim.
Utilize lipase can the hydrolysis of the left-handed leucine methyl ester of selective catalysis enantiomorph in the present invention, obtain left-handed leucine and dextrorotation leucine methyl ester, due to left-handed leucine, solubleness be less in the solution, can separate out from solution; And dextrorotation leucine methyl ester solubleness is comparatively large in the solution, then stay in the solution.After balance for some time, they can be separated by filtering.
The dextrorotation leucine methyl ester obtained is hydrolyzed reaction in the basic conditions, obtains dextrorotation leucine sodium salt.Neutralize through rare strong acid again, generate leucine.The pH of regulator solution is to leucic iso-electric point, and now leucic solubleness is minimum, separates out from solution, filters and namely obtains dextrorotation leucine.
2 splitting condition
DL-LEUCINE methyl ester hydrochloride is dissolved in a certain amount of saturated enzyme liquid, and adds a certain amount of sodium bicarbonate, stir 5 ~ 10 hours at 30 ~ 40 DEG C, then be cooled to room temperature, leach white solid.White solid is left-handed leucine.Containing dextrorotation leucine methyl ester in filtrate, at hydrolyzed under basic conditions such as NaOH, then through diluted acid acidifying, adjust ph, namely obtains the higher D-Leu of optical purity.
Example 1:
Taking 3.62g (0.02mol) leucine methyl ester hydrochloride adds in fine taper bottle, taking 1.68g (0.02mol) sodium bicarbonate again adds in Erlenmeyer flask, and measure 16ml saturated fatty enzyme solution and add in reaction flask, Erlenmeyer flask is put into constant temperature oscillator vibrate, arranging temperature of reaction is 38 DEG C, reaction 8h, then reaction flask Slow cooling cooling, vacuum filtration.Obtaining filter cake is L-Leu 1.02g, and productive rate is 77.86%, specific rotatory power [α] d 20=+14.6 ° of (C=2,6mol.L -1hCl).Containing D-Leu methyl esters in filtrate, in filtrate, add a certain amount of sodium hydroxide, after dissolving, add isopyknic methyl alcohol again, in stirred at ambient temperature 10h, use 1mol.L -1the pH of dilute hydrochloric acid regulator solution to 6, then reacts 1h, and filter, wash filter cake with water, drying obtains D-Leu 0.90g, and yield is 68.70%, [α] d 20=-14.35 ° of (C=2,6mol.L -1hCl).
Example 2:
Taking 3.62g leucine methyl ester hydrochloride adds in fine taper bottle, taking 1.68g (0.02mol) sodium bicarbonate again adds in Erlenmeyer flask, and measure 16ml saturated fatty enzyme solution and add in reaction flask, Erlenmeyer flask is put into constant temperature oscillator vibrate, temperature of reaction is 34 DEG C, reaction times is 8h, then reaction flask Slow cooling cooling, vacuum filtration.Obtaining filter cake is L-Leu 0.92g, and productive rate is 70.22%, specific rotatory power [α] d 20=+14.6 ° of (C=2,6mol.L -1hCl).Containing D-Leu methyl esters in filtrate, in filtrate, add a certain amount of sodium hydroxide, after dissolving, add isopyknic methyl alcohol again, in stirred at ambient temperature 10h, use 1mol.L -1the pH of dilute hydrochloric acid regulator solution to 6, then reacts 1h, and filter, wash filter cake with water, drying obtains D-Leu 0.94g, and yield is 71.76%, [α] d 20=-12.52 ° of (C=2,6mol.L -1hCl).
Example 3:
Taking 3.62g leucine methyl ester hydrochloride adds in fine taper bottle, taking 1.68g sodium bicarbonate again adds in Erlenmeyer flask, and measure 16ml saturated fatty enzyme solution and add in reaction flask, Erlenmeyer flask is put into constant temperature oscillator vibrate, arranging temperature of reaction is 38 DEG C, react 9 hours, then reaction flask Slow cooling cooling, vacuum filtration.Obtaining filter cake is L-Leu 1.19g, specific rotatory power [α] d 20=+14.6 ° of (C=2,6mol.L -1hCl).Containing D-Leu methyl esters in filtrate, in filtrate, add solid sodium hydroxide, after dissolving, add methyl alcohol again, continuously stirring 10h, use 1mol.L -1the pH of dilute hydrochloric acid regulator solution to 6, then reacts 1h, and filter, wash filter cake with water, drying obtains D-Leu 0.83g, and yield is 63.36%, [α] d 20=-14.40 ° of (C=2,6mol.L -1hCl).

Claims (1)

1. the leucic method of resolution of racemic, is characterized in that: the method prepares left-handed leucine and dextrorotation leucine with Enzymatic Resolution racemize leucine and DL-LEUCINE, specifically comprises the following steps:
The first step: with racemize leucine for raw material, prepares DL-LEUCINE methyl ester hydrochloride according to known thionyl chloride method;
Second step: DL-LEUCINE methyl ester hydrochloride is dissolved in alkaline aqueous solution, adds lipase, enzymatic hydrolysis 5 ~ 10 hours at 30 ~ 40 DEG C of temperature, cool to room temperature gradually again, filter out insolubles, obtain left-handed leucine and L-Leu, and retain filtrate;
3rd step: second step gained filtrate continues hydrolysis in the basic conditions, terminates the neutralization of rear diluted acid, filters to obtain dextrorotation leucine and D-Leu;
Wherein:
Described lipase is alkaline lipase;
Described diluted acid comprises dilute hydrochloric acid or dilute sulphuric acid, and the concentration of diluted acid is 0.1-2.0mol/L;
Alkaline aqueous solution in described second step alkali used is: NaOH, KOH, NaHCO 3, Na 2cO 3or ammoniacal liquor;
Alkali required for described 3rd step neutral and alkali condition is LiOH, NaOH, KOH, K 2cO 3or Na 2cO 3.
CN201410167153.5A 2014-04-23 2014-04-23 A kind of leucic method of resolution of racemic Expired - Fee Related CN103981248B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410167153.5A CN103981248B (en) 2014-04-23 2014-04-23 A kind of leucic method of resolution of racemic

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410167153.5A CN103981248B (en) 2014-04-23 2014-04-23 A kind of leucic method of resolution of racemic

Publications (2)

Publication Number Publication Date
CN103981248A CN103981248A (en) 2014-08-13
CN103981248B true CN103981248B (en) 2016-03-16

Family

ID=51273419

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410167153.5A Expired - Fee Related CN103981248B (en) 2014-04-23 2014-04-23 A kind of leucic method of resolution of racemic

Country Status (1)

Country Link
CN (1) CN103981248B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104592052A (en) * 2015-01-06 2015-05-06 宁波海硕生物科技有限公司 Method for preparing N-acetyl-DL-leucine
CN105349609A (en) * 2015-11-23 2016-02-24 浙江理工大学 Method for improving chiral resolution performance of lipase on amino-acid ester in organic phase

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100558905C (en) * 2007-04-30 2009-11-11 江南大学 A kind of enzyme splits the method for preparation (R)-6-hydroxyl-8-chloroctanoic acid ethyl ester
CN101659623A (en) * 2008-08-25 2010-03-03 天津金耀集团有限公司 Method for resolving DL-Amino Acid

Also Published As

Publication number Publication date
CN103981248A (en) 2014-08-13

Similar Documents

Publication Publication Date Title
CN103981248B (en) A kind of leucic method of resolution of racemic
CN108558721A (en) A kind of preparation method of N, N- diacetyl-l-cysteine
CN101659622A (en) Method for splitting valine
Myers et al. A one-step synthesis of pseudoephedrine glycinamide, a versatile precursor for the synthesis of α-amino acids
EP0213785B1 (en) Method for optical resolution of dl-cysteine and (r,s)-1-(1-naphthyl)ethylamine
CN103570638A (en) Synthetic method of florfenicol intermediate cyclic product
CN110330440A (en) A kind of technique that 5-ALA is prepared with 5- chloromethyl furfural
CN109369460A (en) The synthetic method of one kind (2S) -2-N- fluorenylmethyloxycarbonyl amino -2,4- dimethyl valeric acid
CN102516142B (en) Preparation method of chromium methionine chelate
CN103333180B (en) Preparation method of aspoxicillin
HK1123275A1 (en) Novel method for preparing quaternary acid and ammonium salts
CN108997209B (en) Preparation method of regorafenib
CN103012177B (en) L-carnitine preparation method
CN102898338A (en) Alpha-amino acid chromium (III) chelate and preparation method thereof
CN103880756B (en) The preparation method of a kind of Azilsartan intermediate
CN104557677A (en) Chemical resolution preparation method for optical pure 2-pipecolic acid
CN100519514C (en) Method of preparing D-p-hydroxyphenylglycine
CN106316873A (en) Novel method for preparing L-carnitine
CN104592046A (en) Optically active valine compound and production method thereof
CN111333529A (en) Preparation method of pregabalin
CN102887851B (en) Compound 3,5-dimethyl-1H-pyrrole-2,4-diformaldehyde and preparation method thereof
CN106518902A (en) Preparation process method for boron-containing compound
CN105506016A (en) Method for producing DL-aspartic acid by adopting enzyme method
CN107056661A (en) A kind of preparation method of lapatinib intermediate 2 (methylsulfonyl) ethylamine hydrochloride
CN101659623A (en) Method for resolving DL-Amino Acid

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20160316

Termination date: 20190423

CF01 Termination of patent right due to non-payment of annual fee